Effect and Safety of Semaglutide Once-weekly in East Asian Subjects With Overweight or Obesity

Completed Phase 3 NCT03811574

Study Description

This study will look at the change in participants' body weight from the start to the end of the study. This is to compare the effect on body weight in people taking semaglutide (a new medicine) and people taking "dummy" medicine. In addition to taking the medicine, participants will have talks with study staff about healthy food choices, how to be more physically active and what participants can do to lose weight. Participants will either get semaglutide or "dummy" medicine - which treatment participants get is decided by chance. Participants are three times as likely to get semaglutide as "dummy" medicine. Participants will need to take 1 injection once a week. The study medicine is injected with a thin needle in a skinfold in the stomach, thigh or upper arm. The study will last for about one and a half years. Participants will have 14 clinic visits and 11 phone calls with the study doctor.

Study Details

Registry ID:
NCT03811574
Conditions:
Overweight, Obesity
Phase:
Phase 3
Target Enrollment:
401 participants
Start Date:
Age Range:
18–999 years
Healthy Volunteers:
No

Study Locations (20 sites)

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →